ICU Medical (Nasdaq:ICUI) reported first-quarter results that came in ahead of the consensus earnings per share forecast. The San Clemente, California-based company posted losses of $38.1 million, or $1.61 per share, on sales of $543.1 million for the three months ended March 31, 2022, for a bottom-line slide into the red on sales growth of … [Read more...] about ICU Medical beats The Street in Q1
Catheters
Penumbra grows sales 20% in Q1
Penumbra (NYSE:PEN) this week posted first-quarter results that beat the revenue consensus on Wall Street but missed earnings estimates. The Alameda, California-based company reported profits of $79,000, or -1¢ per share, on sales of $203.9 million for the three months ended March 31, for a sales growth of 20.5% compared with Q1 … [Read more...] about Penumbra grows sales 20% in Q1
Avanos rises as Q1 earnings match Wall Street projections
Avanos Medical (NYSE:AVNS) shares ticked up today on first-quarter results that just about matched the consensus forecast. The Alpharetta, Georgia–based pain management and chronic care device company posted profits of $5.8 million, or 12¢ per share, on sales of $197.4 million for the three months ended March 31, 2022, for a bottom-line gain … [Read more...] about Avanos rises as Q1 earnings match Wall Street projections
Boston Scientific wins FDA clearance for Embold fibered detached coil
Boston Scientific (NYSE:BSX) this week announced it received FDA 510(k) clearance for the Embold fibered detachable coil for use in the peripheral vasculature. Marlborough, Massachusetts-based Boston Scientific designed Embold for use in a number of embolization procedures that block one or more blood vessels to obstruct or reduce blood flow. … [Read more...] about Boston Scientific wins FDA clearance for Embold fibered detached coil
Study demonstrates freedom from AFib symptoms with use of Abbott’s ablation catheter
Abbott (NYSE:ABT) announced today that a study showed its TactiCath ablation catheter often led to more than a year of freedom from AFib symptoms. The Persist-End study showed that 89% of patients treated for persistent AFib with the company’s TactiCath contact force ablation catheter, Sensor Enabled (TactiCath SE), remained symptom-free for up … [Read more...] about Study demonstrates freedom from AFib symptoms with use of Abbott’s ablation catheter
LeMaitre Vascular grows sales 10% in Q1 results
Lemaitre Vascular (NSDQ:LMAT) posted first-quarter results that beat the revenue consensus on Wall Street and missed earnings estimates. The Burlington, Massachusetts-based vascular device company reported profits of $6 million, or 27¢ per share on sales of $39.6 million for the three months ended March 31, for a bottom-line gain of 1.8% on … [Read more...] about LeMaitre Vascular grows sales 10% in Q1 results
CathVision completes patient enrollment in ECGenius EP recording system clinical trial
CathVision this week announced it completed patient enrollment in the CathVision ECGenius System clinical study. The company anticipates FDA 510(k) clearance for the ECGenius System within the next two weeks, a company representative said. The clinical evaluation study is being conducted at the University of Vermont Medical Center and will … [Read more...] about CathVision completes patient enrollment in ECGenius EP recording system clinical trial
Abbott announces U.S. launch of Amplatzer steerable delivery sheath for Amulet device
Abbott (NYSE:ABT) announced today that it made the Amplatzer steerable delivery sheath commercially available in the U.S. The Amplatzer steerable delivery sheath works with the Amplatzer Amulet left atrial appendage (LAA) occluder to treat people with AFib who are at risk of ischemic stroke According to a news release, the Amulet with … [Read more...] about Abbott announces U.S. launch of Amplatzer steerable delivery sheath for Amulet device
Acutus Medical sells left-heart access portfolio to Medtronic in $50M deal
Acutus Medical (NSDQ:AFIB) today announced that it has entered a definitive agreement to sell its left-heart access portfolio to Medtronic (NYSE:MDT) for $50 million. Medtronic will make an upfront cash payment to Princeton, N.J.–based Acutus Medical of $50 million upon the initial closing of the transaction, which is subject to the satisfaction … [Read more...] about Acutus Medical sells left-heart access portfolio to Medtronic in $50M deal
18 of the world’s most innovative medical technologies
Judges this week are voting for the most innovative medical technologies among the nominees for the 2022 Prix Galien International Awards. The Prix Galien International Awards highlight the most innovative technologies in the life sciences industry. The New York-based Galien Foundation presents the international award to eligible nominees that … [Read more...] about 18 of the world’s most innovative medical technologies